Company intelligence / Profile preview

Xiusin Pharmaceutical Technology

Nantong, Jiangsu Province, Chinaalltrna.com ↗

Ownership: Private
Development stage: Other

Overview

Xiushi Biopharma is an international high-tech enterprise specializing in large-scale biosynthesis of polypeptide drugs. It offers comprehensive services from drug discovery and CMC development to GMP-compliant manufacturing for global biotech and pharma companies. The company has developed a biosynthetic complex cyclic peptide drug technology platform and collaborates with major pharmaceutical partners in China. It was recognized as a top future medical company and has received several innovation awards since its founding in 2020.

Modalities: PeptidesPolypeptide drugsRecombinant protein
Industry: Drug Discovery Services

Partnerships

Commercial cooperation with major pharmaceutical companies in China via biosynthetic protein CMC projects

Beyond the preview

Go deeper on Xiusin Pharmaceutical Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xiusin Pharmaceutical Technology.

Explore the full profile